We are pleased to announce that GCA Professional Services Group has successfully provided comprehensive equity interest valuation services to Goldstream Investment Limited (Stock Code: 1328.HK) as part of its strategic acquisition initiatives. This collaboration highlights GCA’s commitment to delivering high-quality, value-driven advisory services that support our clients’ investment objectives.
Goldstream Investment operates as a multi-manager, multi-strategy, and multi-asset investment platform powered by artificial intelligence, focusing on leveraging Chinese capital for global investments and attracting international capital into the Chinese market. Our valuation work concentrated on assessing the equity interests of United Strength Fortune Limited (“USFL”) and Feasible Result Investment Limited (“FRI”). USFL, through its subsidiary Suzhou Advaccine Biotechnology Company Limited (“Advaccine”), specializes in developing and producing innovative vaccines and pharmaceuticals, while FRI owns a 100% stake in Shanghai Li Fung Property Management Company Limited, which focuses on property leasing.
The decision to acquire shares in USFL and Advaccine is driven by attractive investment opportunities in the biotechnology sector, whereas the acquisition of shares in FRI is motivated by the anticipated income stream from property rental revenues. These strategic acquisitions align with Goldstream’s vision, as stated in its annual report, to enhance fundraising efforts and identify additional investment opportunities to maximize returns for equity shareholders.
This milestone marks a significant expansion of GCA’s portfolio, allowing us to enter the innovative fields of biotechnology and property management. We remain dedicated to providing invaluable support to our clients and look forward to their continued success in these dynamic industries.